BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
rs3825942
,
FOXP1
,
Apoptosis
,
Inflammatory disorder
,
Adipose tissue
,
Pharmacogenetics
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
BAK
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Plasma cell of spleen
B lymphocyte (IgM memory) of spleen
Macrophage of peripheral blood
Eosinophil of peripheral blood
Granulocyte-macrophage progenitor cell of bone marrow
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Irritable bowel syndrome
Viral carditis
Infection due to Bacteroides
Disorder of intraocular pressure
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Gold nanoparticles
rifapentine
antimycin
Piromidic Acid
Enterotoxins
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
HR
SLC35A3
PCDH7
BAK1
IGH
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
A novel inhibitory BAK antibody enables assessment of non-activated BAK in cancer cells.
Key residues in the VDAC2-BAK complex can be targeted to modulate apoptosis.
Association mechanism between Arabidopsis immune coreceptor BAK1 and Pseudomonas syringae effector H…
Preferred inhibition of pro-apoptotic Bak by BclxL via a two-step mechanism.
Control of lateral root formation by rapamycin-induced dimerization of engineered RGI/BAK1 and by BI…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Efficacy and Tolerability of an Innovative Formulation of BAK-free Latanoprost
The Effects of BAK on the Blood Aqueous Barrier of Pseudophakic Patients
Efficacy of Changing to DuoTrav® (Travoprost 0.004%/Timolol 0.5% BAK-Free Fixed Combination) From Pr…
Efficacy and Toxicity of Bepotastine 1,5% PF vs Olopatadine 0,2% With BAK on Allergic Conjunctivitis…
Dorzolamide+Timolol Multidose Preservative-free vs Dorzolamida+Timolol BAK Preserved Efficacy and Sa…
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ